Table 7.
Number and percentage of patients in validation cohort with estimated cardiovascular risk of ≥20% by five year age band with QRISK2 compared with modified Framingham equation
| Age (years) | Total population | QRISK2 model (%) | Modified Framingham equation |
|---|---|---|---|
| Women | |||
| 35-39 | 78 887 | 16 (0.02) | 4 (0.01) |
| 40-44 | 62 153 | 56 (0.09) | 88 (0.14) |
| 45-49 | 55 879 | 193 (0.35) | 636 (1.14) |
| 50-54 | 49 392 | 517 (1.05) | 2048 (4.15) |
| 55-59 | 40 183 | 1228 (3.06) | 3892 (9.69) |
| 60-64 | 33 831 | 2971 (8.78) | 5952 (17.59) |
| 65-69 | 29 045 | 6657 (22.92) | 7870 (27.10) |
| 70-74 | 26 393 | 13 988 (53.00) | 9581 (36.30) |
| Men | |||
| 35-39 | 85 424 | 97 (0.11) | 289 (0.34) |
| 40-44 | 67 911 | 345 (0.51) | 1570 (2.31) |
| 45-49 | 58 085 | 910 (1.57) | 4703 (8.10) |
| 50-54 | 49 171 | 2336 (4.75) | 9635 (19.59) |
| 55-59 | 38 955 | 4986 (12.90) | 14 330 (36.79) |
| 60-64 | 30 849 | 9649 (31.28) | 17 008 (55.13) |
| 65-69 | 24 924 | 15 905 (63.81) | 18 117 (72.69) |
| 70-74 | 19 150 | 18 170 (94.88) | 16 433 (85.61) |
| Totals | |||
| Women | 375 763 | 25 626 (6.82) | 30 071 (8.00) |
| Men | 374 469 | 52 398 (13.99) | 82 085 (21.92) |
| Both | 750 232 | 78 024 (10.40) | 112 156 (14.95) |